Tonix Pharmaceuticals Holding Corp.
TNXP
$13.29
$0.050.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -112.19% | -125.22% | 64.11% | -12.65% | 19.08% |
| Total Depreciation and Amortization | -1.61% | -54.36% | -46.63% | -51.19% | -66.91% |
| Total Amortization of Deferred Charges | -100.00% | 100.00% | -100.00% | -87.05% | 184.03% |
| Total Other Non-Cash Items | 211.48% | 63.20% | -91.16% | 155.98% | -89.10% |
| Change in Net Operating Assets | -12.22% | 109.30% | 53.89% | -381.72% | 1,667.49% |
| Cash from Operations | -171.02% | -53.09% | -49.54% | 5.67% | 34.51% |
| Capital Expenditure | -62,366.67% | -10,588.89% | -- | 94.44% | 99.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -33,933.33% | -10,588.89% | -- | 94.44% | 99.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | -4,006.38% | -- |
| Issuance of Common Stock | -21.54% | 113.43% | 15.67% | 280,334.78% | 700.53% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.98% | -33.74% | 89.65% | -- | -115.97% |
| Cash from Financing | -30.55% | 121.10% | 56.48% | 23,464.62% | 109.15% |
| Foreign Exchange rate Adjustments | -158.33% | 76.47% | -500.00% | -125.00% | 340.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.84% | 170.43% | -120.64% | 284.03% | 293.38% |